Huaibo Sun

Genecast Biotechnology Co., Ltd

SCHOLARLY PAPERS

1

DOWNLOADS

55

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Neo Adjuvant Pyrotinib and Trastuzumab in HER2-Positive Breast Cancer with No Early Response (NeoPaTHer): Primary Analysis of a Prospective,  Multicenter, Response-Adapted Study

Number of pages: 34 Posted: 30 Aug 2023
Fei Wang, Yongjiu Wang, Bin Xiong, Zhenlin Yang, Jingfen Wang, Yumin Yao, Lixiang Yu, Qinye Fu, Liang Li, Qiang Zhang, Chao Zheng, Shuya Huang, Liyuan Liu, Chun Liu, Huaibo Sun, Beibei Mao and Zhigang Yu
Shandong University - Department of Breast Surgery, Shandong University - Department of Breast Surgery, Jining Medical University - Department of Breast Surgery, Binzhou Medical University - Department of Breast Surgery, Linyi Cancer Hospital - Department of Breast Surgery, Liaocheng People's Hospital - Department of Breast Surgery, Shandong University - Department of Breast Surgery, Shandong University - Department of Breast Surgery, Shandong University - Department of Breast Surgery, Shandong University - Department of Breast Surgery, Shandong University - Department of Breast Surgery, Shandong University - Department of Breast Surgery, Shandong University - Department of Breast Surgery, Genecast Biotechnology Co., Ltd, Genecast Biotechnology Co., Ltd, Genecast Biotechnology Co., Ltd and Shandong University - Department of Breast Surgery
Downloads 55 (815,133)

Abstract:

Loading...

Breast cancer, Pyrotinib, Early response, Response-adapted, Neoadjuvant setting, HER2 positive